Surgimab (France)

Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study

Leonora S. F. Boogerd, Charlotte E.S. Hoogstins, Dennis P. Schaap et al. · ˜The œLancet. Gastroenterology & hepatology · 2018 · 190 citations · Full text

Surgical Oncology, Cancer Detection, Medicine +8

Image-Guided Surgery in Patients with Pancreatic Cancer: First Results of a Clinical Trial Using SGM-101, a Novel Carcinoembryonic Antigen-Targeting, Near-Infrared Fluorescent Agent

Charlotte E.S. Hoogstins, Leonora S. F. Boogerd, Babs G. Sibinga Mulder et al. · Annals of Surgical Oncology · 2018 · 150 citations · Full text

SGM-101: An innovative near-infrared dye-antibody conjugate that targets CEA for fluorescence-guided surgery

Marian Gutowski, Bérénice Framery, Martin C. Boonstra et al. · Surgical Oncology · 2017 · 105 citations · Full text

Dose-Finding Study of a CEA-Targeting Agent, SGM-101, for Intraoperative Fluorescence Imaging of Colorectal Cancer

Kim S. de Valk, Marion M. Deken, Dennis P. Schaap et al. · Annals of Surgical Oncology · 2020 · 68 citations · Full text

Intraoperative detection of colorectal and pancreatic liver metastases using SGM-101, a fluorescent antibody targeting CEA

R.P. Meijer, Kim S. de Valk, Marion M. Deken et al. · European Journal of Surgical Oncology · 2020 · 33 citations

Surgical Oncology, Pancreatic Cancer, Hepatology +13